Literature DB >> 18635699

Neural markers of symptomatic improvement during antidepressant therapy in severe depression: subgenual cingulate and visual cortical responses to sad, but not happy, facial stimuli are correlated with changes in symptom score.

P Keedwell1, D Drapier, S Surguladze, V Giampietro, M Brammer, M Phillips.   

Abstract

Resting state activity in the ventral cingulate may be an important neural marker of symptomatic improvement in depression. The number of task related functional magnetic resonance imaging (fMRI) studies correlating blood oxygenation level dependent (BOLD) response with symptomatic improvement is limited and methodologies are still evolving. We measured BOLD responses to sad and happy facial stimuli in 12 severely depressed individuals in the early stages of antidepressant treatment (Time 1) and 12 weeks later (Time 2) using event-related fMRI. We calculated correlations between temporal changes in BOLD response and changes in symptom scores. Most subjects improved markedly by Time 2. At Time 1, depression severity correlated positively with responses to sad stimuli in the right visual cortex, subgenual cingulate, anterior temporal pole and hippocampus and correlated negatively with responses to happy stimuli in left visual cortex and right caudate. Decreases in individual effect sizes of right subgenual cingulate and right visual cortical responses to sad, but not happy, facial stimuli were correlated with decreases in symptom scores. There are contrasting cortical and subcortical responses to sad and happy stimuli in severe depression. Responses to sad stimuli show the strongest correlates of clinical improvement, particularly in the subgenual cingulate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18635699     DOI: 10.1177/0269881108093589

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  44 in total

Review 1.  Frontocingulate dysfunction in depression: toward biomarkers of treatment response.

Authors:  Diego A Pizzagalli
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

2.  Neural correlates of social exclusion during adolescence: understanding the distress of peer rejection.

Authors:  Carrie L Masten; Naomi I Eisenberger; Larissa A Borofsky; Jennifer H Pfeifer; Kristin McNealy; John C Mazziotta; Mirella Dapretto
Journal:  Soc Cogn Affect Neurosci       Date:  2009-06       Impact factor: 3.436

3.  The infralimbic cortex bidirectionally modulates mesolimbic dopamine neuron activity via distinct neural pathways.

Authors:  Mary H Patton; Brandon T Bizup; Anthony A Grace
Journal:  J Neurosci       Date:  2013-10-23       Impact factor: 6.167

4.  Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological considerations.

Authors:  Steven G Potkin; Jessica A Turner; Guia Guffanti; Anita Lakatos; Federica Torri; David B Keator; Fabio Macciardi
Journal:  Cogn Neuropsychiatry       Date:  2009       Impact factor: 1.871

5.  Identification of Mood-Relevant Brain Connections Using a Continuous, Subject-Driven Rumination Paradigm.

Authors:  Anna-Clare Milazzo; Bernard Ng; Heidi Jiang; William Shirer; Gael Varoquaux; Jean Baptiste Poline; Bertrand Thirion; Michael D Greicius
Journal:  Cereb Cortex       Date:  2014-10-19       Impact factor: 5.357

6.  Ventromedial prefrontal cortex is critical for the regulation of amygdala activity in humans.

Authors:  Julian C Motzkin; Carissa L Philippi; Richard C Wolf; Mustafa K Baskaya; Michael Koenigs
Journal:  Biol Psychiatry       Date:  2014-02-26       Impact factor: 13.382

7.  Does low self-esteem enhance social pain? The relationship between trait self-esteem and anterior cingulate cortex activation induced by ostracism.

Authors:  Keiichi Onoda; Yasumasa Okamoto; Ken'ichiro Nakashima; Hiroshi Nittono; Shinpei Yoshimura; Sigeto Yamawaki; Shuhei Yamaguchi; Mitsuhiro Ura
Journal:  Soc Cogn Affect Neurosci       Date:  2010-02-09       Impact factor: 3.436

8.  Decreased occipital cortical glutamate levels in response to successful cognitive-behavioral therapy and pharmacotherapy for major depressive disorder.

Authors:  Chadi G Abdallah; Mark J Niciu; Lisa R Fenton; Madonna K Fasula; Lihong Jiang; Anne Black; Douglas L Rothman; Graeme F Mason; Gerard Sanacora
Journal:  Psychother Psychosom       Date:  2014-08-06       Impact factor: 17.659

Review 9.  Imaging phenotypes of major depressive disorder: genetic correlates.

Authors:  J B Savitz; W C Drevets
Journal:  Neuroscience       Date:  2009-04-07       Impact factor: 3.590

10.  An fMRI study of emotional face processing in adolescent major depression.

Authors:  Leah M J Hall; Bonnie Klimes-Dougan; Ruskin H Hunt; Kathleen M Thomas; Alaa Houri; Emily Noack; Bryon A Mueller; Kelvin O Lim; Kathryn R Cullen
Journal:  J Affect Disord       Date:  2014-07-02       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.